文献速递冠心病

髓系PlexinD1缺失通过抑制经典巨噬细胞极化减轻低剪切应力部位的动脉粥样硬化进展

Atherosclerotic progression at sites of low shear stress is attenuated by myeloid-PlexinD1 deficiency through suppression of classical macrophage polarization.
PubMed 文献 · Eur Heart J · 2026-01-01

研究在72例ACS患者中量化血浆PlexinD1并按冠状动脉分叉病变分层,比较颈动脉分叉处(振荡剪切应力,OSS)与近端颈总动脉(层流剪切应力,LSS)斑块,并构建髓系PlexinD1敲除小鼠及靶向纳米颗粒。结果显示分叉病变患者血浆PlexinD1升高1.32倍,OSS通过下调内皮PTGS2/PGE2促进PlexinD1/NF-κB依赖的M1巨噬细胞极化,髓系PlexinD1缺失减轻动脉粥样硬化病变。

要点

  • 冠状动脉分叉病变患者血浆PlexinD1水平升高1.32倍。
  • OSS通过抑制内皮PTGS2/PGE2促进PlexinD1/NF-κB依赖的M1极化。
  • 髓系PlexinD1缺失可减轻动脉粥样硬化病变。

核心结论

  • OSS通过抑制内皮PTGS2/PGE2促进PlexinD1/NF-κB介导的M1巨噬细胞极化驱动动脉粥样硬化进展。
  • PlexinD1是识别和稳定动脉粥样硬化病变的有前景靶点。

研究设计与样本

  • 量化72例急性冠脉综合征(ACS)患者血浆PlexinD1,按冠状动脉分叉病变受累分层。
  • 比较颈动脉分叉处(暴露于OSS)与近端颈总动脉(暴露于LSS)斑块。
  • 构建髓系PlexinD1敲除小鼠,在载脂蛋白E缺陷背景上以高脂高胆固醇饮食诱导动脉粥样硬化。
  • 开发PlexinD1靶向多模态纳米颗粒用于成像。
  • 通过共培养内皮细胞与巨噬细胞在OSS或LSS下的蛋白质组和分子分析探索机制。

主要发现

  • 冠状动脉分叉病变患者血浆PlexinD1水平升高1.32倍。
  • 人颈动脉分叉病变较颈总动脉斑块同时显示PlexinD1表达增加、M1巨噬细胞极化和斑块易损性增加。
  • 动脉粥样硬化小鼠中髓系PlexinD1缺失通过抑制M1巨噬细胞极化减轻病变。
  • OSS下调PTGS2/PGE2,从而促进PlexinD1/NF-κB依赖的M1巨噬细胞极化。
  • PlexinD1靶向多模态成像纳米颗粒可在体内识别和监测分叉病变。

临床怎么用

  • 血浆PlexinD1可能作为分叉病变相关ACS患者的生物标志物。
  • PlexinD1靶向多模态纳米颗粒有望用于在体识别和监测分叉病变。
  • 靶向PlexinD1/NF-κB通路或抑制M1极化可能稳定易损斑块。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Atherosclerosis preferentially develops at disturbed flow sites, where macrophage polarization critically determines plaque vulnerability. PlexinD1 may regulate this process by mediating M1 macrophage polarization under low and oscillatory shear stress (OSS). This study aims to investigate the role of macrophage PlexinD1 in OSS-induced atherosclerotic progression. METHODS: Plasma PlexinD1 was quantified in 72 patients with acute coronary syndrome (ACS) stratified by coronary bifurcation lesion involvement. Plaques in carotid bifurcations (exposed to OSS) and those in proximal common carotid arteries (exposed to laminar shear stress, LSS) were compared to investigate the differential effects of OSS vs LSS. Myeloid-PlexinD1 knockout mice were generated to investigate its role in atherosclerosis, which was induced by exposure to a high-fat, high-cholesterol diet on an apolipoprotein E-deficient background. PlexinD1-targeted multi-modal nanoparticles were developed for imaging. PlexinD1-centric regulatory mechanisms were explored through proteomic and molecular analyses of co-cultured endothelial cells and macrophages subjected to OSS or LSS. RESULTS: Patients with coronary bifurcation lesions exhibited 1.32-fold higher plasma PlexinD1 levels. Human carotid bifurcation lesions demonstrated concurrently increased PlexinD1 expression, M1 macrophage polarization, and plaque vulnerability compared with plaques in common carotid arteries. In atherosclerotic mice, myeloid-PlexinD1 deletion attenuated lesions by suppressing M1 macrophage polarization. OSS down-regulated PTGS2/PGE2, thereby promoting PlexinD1/NF-κB-dependent M1 macrophage polarization. PlexinD1-targeted multi-modal imaging nanoparticles enabled in vivo identification and monitoring of bifurcation lesions. CONCLUSIONS: OSS drives atherosclerotic progression by suppressing endothelial PTGS2/PGE2 to promote PlexinD1/NF-κB-mediated M1 macrophage polarization. PlexinD1 represents a promising target to identify and stabilize atherosclerotic lesions.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Ma, Zhang, Gao, et al. Atherosclerotic progression at sites of low shear stress is attenuated by myeloid-PlexinD1 deficiency through suppression of classical macrophage polarization. Eur Heart J. 2026. PMID: 41405851. doi:10.1093/eurheartj/ehaf991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。